The Stem Cells Transplant Institute is partnering with N-BIOTEK, the world leader in stem cell manufacturing and processing. N-BIOTEK, Inc. was founded in 2000 and is the only company in the world that focuses on the entire stem cell processing system from beginning to end; from the construction of the biologic clean room to equipment manufacturing and installation. By partnering with N-BIOTEK, the Stem Cells Transplant Institute is able to provide stem cell treatments using the highest quality and technologically advanced equipment. Every product N-BIOTEK manufactures is made to comply with, or exceed North American, European and International quality and safety standards, and must receive ETL, CE, GMP and ISO certification.
The Stem Cells Transplant Institute and N-BIOTEK are both leaders in the field of life sciences and regenerative medicine. By partnering with N-BIOTEK, the professionals at the Stem Cells Transplant Institute will have access to the most advanced technologies and be able to provide the highest quality of care while still maintaining competitive pricing. Competitive pricing means more patients can have access to the benefits of stem cell treatment.
Exciting progress is being made through innovative research, evaluating the safety and efficacy of stem cell transplantation for the treatment of debilitating diseases that lack adequate treatment options including; multiple sclerosis, lupus, Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, diabetes and cardiovascular disease. By partnering together, the Stem Cells Transplant Institute and N-BIOTEK will continue to lead the effort to better understand the power and potential of stem cells to treat disease.